Neurological features of Hansen disease: a retrospective, multicenter cohort study

• Published in: Scientific reports Vol. 14; no. 1; pp. 10374 - 20
• Main Authors: Chen, Xiaohua, Di, Li, Qian, Min, Shen, Dongchao, Feng, Xinhong, Zhang, Xiqing
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 06-05-2024; Nature Publishing Group; Nature Portfolio
• Subjects: 692/1807; 692/308; 692/617; 692/699; Adult; Aged; Biopsy; Demyelination; Electrophysiology; Engines; Female; Humanities and Social Sciences; Humans; Leprosy; Leprosy - complications; Leprosy - diagnosis; Leprosy - pathology; Lesions; Male; Medical records; Middle Aged; multidisciplinary; Muscle strength; Nerves; Neurology; Pathology; Peripheral nerves; Peripheral Nervous System Diseases - diagnosis; Peripheral Nervous System Diseases - pathology; Peripheral neuropathy; Retrospective Studies; Science; Science (multidisciplinary); Sensory neurons; Serology; Skin diseases; Skin lesions; Young Adult; United States > US
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-60457-0

To elucidate the neurological features of Hansen disease. The medical records of patients with confirmed Hansen disease transferred from the neurology department were reviewed, and all medical and neurological manifestations of Hansen disease were assessed. Eleven patients with confirmed Hansen disease, 10 with newly detected Hansen disease and 1 with relapsed Hansen disease, who visited neurology departments were enrolled. The newly detected patients with Hansen disease were classified as having lepromatous leprosy (LL, n = 1), borderline lepromatous leprosy (BL, n = 2), borderline leprosy (BB, n = 2), borderline tuberculoid leprosy (BT, n = 1), tuberculoid leprosy (TT, n = 2), or pure neural leprosy (PNL, n = 2). All of the patients with confirmed Hansen were diagnosed with peripheral neuropathy (100.00%, 11/11). The symptoms and signs presented were mainly limb numbness (100.00%, 11/11), sensory and motor dysfunction (100.00%, 11/11), decreased muscle strength (90.90%, 10/11), and skin lesions (81.81%, 9/11). Nerve morphological features in nerve ultrasonography (US) included peripheral nerve asymmetry and segmental thickening (100.00%, 9/9). For neuro-electrophysiology feature, the frequency of no response of sensory nerves was significantly higher than those of motor nerves [(51.21% 42/82) vs (24.70%, 21/85)(P = 0.0183*)] by electrodiagnostic (EDX) studies. Nerve histological features in nerve biopsy analysis included demyelination (100.00%, 5/5) and axonal damage (60.00%, 3/5). In addition to confirmed diagnoses by acid-fast bacteria (AFB) staining (54.54%, 6/11) and skin pathology analysis (100.00%, 8/8), serology and molecular technology were positive in 36.36% (4/11) and 100.00% (11/11) of confirmed patients of Hansen disease, respectively. It is not uncommon for patients of Hansen disease to visit neurology departments due to peripheral neuropathy. The main pathological features of affected nerves are demyelination and axonal damage. The combination of nerve US, EDX studies, nerve biopsy, and serological and molecular tests can improve the diagnosis of Hansen disease.